Our R&D portfolio for visceral leishmaniasis
What we have achieved
We have delivered new treatments using existing drugs to make treatments shorter, safer and more effective.
What we are doing for people with visceral leishmaniasis
We are working to deliver better combination treatments and new drugs. Together with our partners, we have built an unprecedented portfolio of six new chemical classes, with different mechanisms of action against Leishmania parasites.
Get our latest news, personal stories, research articles, and job opportunities.